Search Results - "Shamir, Eyal"

Probing the Magnocellular and Parvocellular Visual Pathways in Facial Emotion Perception in Schizophrenia by Jahshan, Carol, Wolf, Maor, Karbi, Yinnon, Shamir, Eyal, Rassovsky, Yuri

“…Abstract Schizophrenia patients have well-established deficits in facial emotion perception, which contribute to their poor social functioning. A number of…”
Get full text

Do biometric parameters of the hand differentiate schizophrenia from other psychiatric disorders? A comparative evaluation using three mental health modules by Zvi Shamir, Eyal, Levy, Anat, Morris Cassan, Stanley, Lifshitz, Tova, Shefler, Gaby, Tarrasch, Ricardo

“…Abstract The link between schizophrenia and anomalies in the distal upper limb is well documented. Preliminary studies have identified a number of biometric…”
Get full text

Clinical utility of biomarkers of the hand in the diagnosis of schizophrenia by Domany, Yoav, Levy, Anat, Cassan, Stanley Morris, Tarrasch, Ricardo, Lifshitz, Tova, Schreiber, Shaul, Shamir, Eyal Zvi

“…A number of biomarkers were assessed in photos and prints of the hands of 95 patients with a variety of mental disorders to determine whether patients with…”
Get full text

REM sleep latency and wakefulness in the first sleep cycle as markers of major depression by Rotenberg, Vadim S, Shamir, Eyal, Barak, Yoram, Indursky, Peter, Kayumov, Leonid, Mark, Mordechai

Get full text

Methadone maintenance treatment and survival of schizophrenic patients with a lifetime comorbid substance use disorders: a long-term follow-up study by Gimelfarb, Yuri, Shamir, Eyal Zvi, Ness Dabush, Keren, Ben Tzarfati, Mashit

“…Background Methadone maintenance treatment (MMT) remains the most widely used effective therapeutic approach for opioid use disorders. However, there is…”
Get full text

Biometric parameters of the hand as an index of schizophrenia—A preliminary study by Shamir, Eyal Zvi, Cassan, Stanley Morris, Levy, Anat, Lifshitz, Tova, Tarrasch, Ricardo

“…Abstract Since abnormalities in distal upper limb development are among the minor physical anomalies associated with schizophrenia we attempted to determine…”
Get full text

The magnocellular visual pathway and facial emotion misattribution errors in schizophrenia by Bedwell, Jeffrey S., Chan, Chi C., Cohen, Ovad, Karbi, Yinnon, Shamir, Eyal, Rassovsky, Yuri

“…Many individuals with schizophrenia show impairment in labeling the emotion depicted by faces, and tend to ascribe anger or fear to neutral expressions…”
Get full text

Association between golli-MBP and schizophrenia in the Jewish Ashkenazi population: are regulatory regions involved? by Baruch, Kuti, Silberberg, Gilad, Aviv, Alex, Shamir, Eyal, Bening-Abu-Shach, Ulli, Baruch, Yehuda, Darvasi, Ariel, Navon, Ruth

“…Multiple studies have reported oligodendrocyte and myelin abnormalities, as well as dysregulation of their related genes, in brains of schizophrenia patients…”
Get full text

Melatonin improves sleep quality of patients with chronic schizophrenia by Shamir, E, Laudon, M, Barak, Y, Anis, Y, Rotenberg, V, Elizur, A, Zisapel, N

“…Accumulating evidence indicates decreased melatonin levels in patients with schizophrenia. Insomnia, mainly difficulty in falling asleep at night, is commonly…”
Get full text

Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study by BARAK, Yoram, SHAMIR, Eyal, WEIZMAN, Ronit

“…Elderly chronic schizophrenia patients are particularly difficult to treat because of aging-related changes, cognitive impairment, and comorbid physical…”
Get full text

The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia by Iancu, Iulian, Poreh, Amir, Lehman, Benny, Shamir, Eyal, Kotler, Moshe

“…The assessment of various symptoms in schizophrenia has received much interest, although few studies have compared evaluations by clinicians to those of their…”
Get full text

Olanzapine vs. haloperidol in the treatment of elderly chronic schizophrenia patients by Barak, Yoram, Shamir, Eyal, Zemishlani, Hanna, Mirecki, Ilona, Toren, Paz, Weizman, Ronit

“…Objective: Most of the data supporting the use of atypical antipsychotics (AA) is based on studies in young adult patients. The present study is an open-label…”
Get full text

Switching elderly chronic psychotic patients to olanzapine by Barak, Yoram, Shamir, Eyal, Mirecki, Ilona, Weizman, Ronit, Aizenberg, Dov

“…The purpose of this study was to examine whether elderly chronic schizophrenia or schizoaffective disorder patients would clinically improve if switched to…”
Get full text

Is melatonin treatment effective for tardive dyskinesia? by SHAMIR, E, BARAK, Y, PLOPSKY, I, ZISAPEL, N, ELIZUR, A, WEIZMAN, A

“…Tardive dyskinesia is a severe and disabling side effect of conventional antipsychotic treatment, with incidence rates reaching a high of 50% in chronically…”
Get full text

REM sleep latency and wakefulness in the first sleep cycle as markers of major depression: A controlled study vs. schizophrenia and normal controls by Rotenberg, Vadim S, Shamir, Eyal, Barak, Yoram, Indursky, Peter, Kayumov, Leonid, Mark, Mordechai

“…Introduction: REM sleep latency is a clinically significant sleep variable that is found to be decreased in several psychiatric disorders. However, it is not…”
Get full text

First-night effect of melatonin treatment in patients with chronic schizophrenia by SHAMIR, Eyal, ROTENBERG, Vadim S, LAUDON, Moshe, ZISAPEL, Nava, ELIZUR, Avner

“…The first-night effect (FNE) is the tendency for individuals to sleep worse than normal during their first night of polysomnographic sleep evaluation. FNE…”
Get full text

Vitamin E (alpha-tocopherol) in the treatment of tardive dyskinesia: a statistical meta-analysis by Barak, Y, Swartz, M, Shamir, E, Stein, D, Weizman, A

“…Tardive dyskinesia is an involuntary movement disorder developing following treatment with neuroleptics. As many as 50% of chronic psychotic patients develop…”
Get more information

Melatonin Treatment for Tardive Dyskinesia: A Double-blind, Placebo-Controlled, Crossover Study by Shamir, Eyal, Barak, Yoram, Shalman, Irena, Laudon, Moshe, Zisapel, Nava, Tarrasch, Ricardo, Elizur, Avner, Weizman, Ronit

“…BACKGROUND Antipsychotics remain the mainstay of drug intervention in the management of schizophrenia. However, long-term treatment with antipsychotics is…”
Get full text

Melatonin treatment for tardive dyskinesia : A double-blind, placebo-controlled, crossover study. Commentary by SHAMIR, Eyal, BARAK, Yoram, GOFF, Don, SHALMAN, Irena, LAUDON, Moshe, ZISAPEL, Nava, TARRASCH, Ricardo, ELIZUR, Avner, WEIZMAN, Ronit, GLAZER, William M, WOODS, Scott W

Get full text